Nuclear Medicine

BWXT Medical, formerly known as the Nuclear Medicine business unit of BWX Technologies, is a leading provider of radiopharmaceutical products and services. The company specializes in the development and manufacturing of medical isotopes, including molybdenum-99 and technetium-99m generators, which are essential for millions of diagnostic imaging procedures annually. BWXT Medical also focuses on the production of therapeutic isotopes such as actinium-225 and lutetium-177 to support the growing field of targeted alpha therapy and radioligand therapy. With facilities in Canada and the United States, the company serves a global customer base of hospitals, pharmacies, and pharmaceutical companies. BWXT Medical is a key player in the nuclear medicine supply chain, ensuring reliable access to life-saving diagnostic and therapeutic agents.